Ing Groep Nv Nektar Therapeutics Transaction History

Ing Groep Nv

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$15.87 - $23.12 $173,601 - $252,909	-10,939 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$16.91 - $36.27 $184,978 - $396,757	10,939 New	10,939 $199,000
Q2 2019 Aug 12, 2019	SELL	$31.0 - $36.3 $320,261 - $375,015	-10,331 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$31.58 - $46.35 $326,252 - $478,841	10,331 New	10,331 $347,000
Q4 2018 Feb 13, 2019	SELL	$30.43 - $56.65 $156,105 - $290,614	-5,130 Closed	0 $0

Q3 2018 Nov 06, 2018	BUY	$46.46 - $68.49 $238,339 - $351,353	5,130 New	5,130 $313,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.